Antares Pharma Inc. (ATRS) Fundamentals

Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
SHARE INFORMATION
Market Cap$ 953,356,543
Shares Outstanding170,852,427
Float166,793,067
Percent Float97.62%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 183,982,000
Latest Fiscal EPS$ 0.26
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions379
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months12,897,827
Institutional Holdings Percent92.1%
Institutional Sold Previous 3 Months11,749,052
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent10.4
Insider Sold Previous 3 Months-
Insider Shares Owned17,670,643
TRADING INFO
52 Week High$ 5.59
52 Week Low$ 3.11
52 Week High Change$ 38.12
21 Day Moving Average$ 5.5683
21 Day Extended Moving Average$ 5.4015
50 Day Moving Average$ 4.7253
50 Day Extended Moving Average$ 4.8922
200 Day Moving Average$ 3.8815
200 Day Extended Moving Average$ 4.1097
10 Day Average Volume3,169,525
20 Day Average Volume5,213,612
30 Day Average Volume8,794,150
50 Day Average Volume5,666,095
Alpha0.010387
Beta1.1462
Standard Deviation0.159349
R20.115946
7 Day Price Change$ 0.02
7 Day Percent Change0.36%
21 Day Price Change$ 0.02
21 Day Percent Change0.36%
30 Day Price Change$ 0.02
30 Day Percent Change0.36%
Month to Date Price Change$ 0.015
Month to Date Percent Change0.27%
Quarter to Date Price Change$ 1.48
Quarter to Date Percent Change36.1%
180 Day Price Change$ 2.12
180 Day Percent Change61.27%
200 Day Price Change$ 1.84
200 Day Percent Change49.2%
Year to Date Price Change$ 2.01
Year to Date Percent Change56.3%

Antares Pharma Inc. (ATRS) Key Ratios

PROFITABILITY
EBIT Margin31.4%
EBITDA Margin33.5%
Pre-Tax Profit Margin11.3%
Profit Margin Count22.94%
Gross Margin61.5%
Profit Margin TOT22.94%
INCOME STATEMENTS
Revenue$ 183,456,000
Revenue Per Share$ 1.0738
Revenue (3 Years)$ 28.38
Revenue (5 Years)$ 32.03
FINANCIAL STRENGTH
Price to Tangible Book6.10
Total Debt To Equity0.20
Int Coverage20.40
Current Ratio3.10
Leverage Ratio1.50
Quick Ratio2.80
Long Term Debt To Capital0.12
VALUATION MEASURES
PE Ratio24.20
Enterprise Value$ 914,924,018
Price to Sales5.1967
Price to Free Cash91.20
PE High Last 5 Years0.00
Price To Book5.40
Price To Cash Flow32.50
PE Low Last 5 Years0.00
Price to Tangible Book6.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover4.70
Assets Turnover0.80
Return Assets17.39
Return on Equity27.24
Return on Capital22.57

Antares Pharma Inc. (ATRS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEORobert F. Apple
Emplyoees203
Last AuditUQ
CIK0001016169
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address100 Princeton South
Suite 300
Ewing, NJ 8628
Websitehttps://www.antarespharma.com
Facsimile-
Telephone+1 609 359-3020
Emailjhowarth@antarespharma.com


Your Recent History
NASDAQ
ATRS
Antares Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.